The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis

International Journal of Pediatric Otorhinolaryngology

Volumn 71, Issue 6, 2007, Pages 843-849

  Dizdar, E A ^a   Sekerel, B E ^a   Keskin, O ^a   Kalayci, O ^a   Adalioglu, G ^a   Dogan, C ^a   Tuncer, A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Allergic rhinitis; Children; Desloratadine; On demand

Indexed keywords

DESLORATADINE; METHACHOLINE; SALBUTAMOL;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; POLLEN ALLERGY; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SEASONAL VARIATION;

ADOLESCENT; ALBUTEROL; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; EPHEDRINE; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; IMMUNOGLOBULIN E; LORATADINE; MALE; METHACHOLINE CHLORIDE; NASAL MUCOSA; NASAL PROVOCATION TESTS; POLLEN; PROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; SECRETORY RATE;

EID: 34247625010     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2007.02.003     Document Type: Article

References (15)

1. Wright A.L., Holberg C.J., Martinez F.D., Halonen M., Morgan W., and Taussig L.M. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 94 (1994) 895-901
2. Salib R.J., Drake-Lee A., and Howarth P.H. Allergic rhinitis: past, present and the future. Clin. Otolaryngol. 28 (2003) 291-303
3. Storms W.W. Rethinking our approach to allergic rhinitis management. Ann. Allergy Asthma. Immunol. 88 (2002) 30-35
4. Rosenwasser L.J. Treatment of allergic rhinitis. Am. J. Med. 113 Suppl 9A (2002) 17-24
5. Horak F., Stubner U.P., Zieglmayer R., and Harris A.G. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J. Allergy Clin. Immunol. 109 (2002) 956-961
6. Meltzer E.O., Jalowayski A.A., Vogt K., Iezzoni D., and Harris A.G. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial. Ann. Allergy Asthma Immunol. 96 (2006) 363-368
7. Bachert C. Therapeutic points of intervention and clinical implications: role of desloratadine. Allergy 57 Suppl. 75 (2002) 13-18
8. Henz B.M. The pharmacologic profile of desloratadine: a review. Allergy 56 (2001) 7-13
9. Ciprandi G., Ricca V., Passalacqua G., Truffelli T., Bertolini C., Fiorino N., et al. Seasonal rhinitis and azelastine: long- or short-term treatment?. J. Allergy Clin. Immunol. 99 (1997) 301-307
10. Ciprandi G., Passalacqua G., Mincarini M., Ricca V., and Canonica G.W. Continuous versus on demand treatment with cetirizine for allergic rhinitis. Ann. Allergy Asthma Immunol. 79 (1997) 507-511
11. Ciprandi G., Ricca V., Tosca M., Landi M., Passalacqua G., and Canonica G.W. Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy. Allergy 54 (1999) 358-365
12. Borish L. Allergic rhinitis: systemic inflammation and implications for management. J. Allergy Clin. Immunol. 112 (2003) 1021-1031
13. Tsicopoulos A., and Nadai P. Antihistamines as anti-inflammatory agents. Clin. Exp. Allergy 33 (2003) 1476-1478
14. Braman S.S., Barrows A.A., DeCotiis B.A., Settipane G.A., and Corrao W.M. Airway hyperresponsiveness in allergic rhinitis A risk factor for asthma. Chest 91 (1987) 671-674
15. Suzina A.H., Hamzah M., and Samsudin A.R. Objective assessment of nasal resistance in patients with nasal disease. J. Laryngol. Otol. 117 (2003) 609-613